Oxford Astrazeneca

Study finds slightly increased blood clot rates after first shot of AstraZaneca's COVID-19 vaccine

The findings are based on 2,80,000 people aged 18-65 who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine in Denmark and Norway

File complaint about threats, will conduct in-depth probe: Maharashtra govt tells Adar Poonawalla

The SII CEO, who has been in the UK on an extended stay to evade alleged threats in India over the ever-increasing demand for COVID-19 vaccines, has said he will return in a few days

WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months

The UN body has also sought a meeting with the Drugs Controller General of India to discuss the matter 10:12

China wanted to show off its COVID-19 vaccines to the world, but the move is backfiring

A YouGov survey this month of roughly 19,000 people in 17 countries and regions showed that most were distrustful of a COVID-19 vaccine made in China

COVID-19 vaccination: 447 recipients across India suffer adverse events post inoculation; how AEFI is tracked, reported

With COVID-19 making the immunisation of adults necessary, the Centre has involved cardiologists, neurologists, general physicians, and pulmonologists in the AEFI committees at national, state, and district levels

Over 1.91 lakh healthcare, sanitary workers get COVID-19 vaccine jabs; no cases of post-vaccination hospitalisation, says Centre

The Union health ministry that the programme had been a "success" as no cases of post-vaccination hospitalisation had been reported as of 7 pm on Saturday

COVID-19 vaccine: DCGI grants approval to Covishield, Covaxin; Modi terms it 'decisive turning point'

The DCGI's approval was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)

Coronavirus News Updates: COVID-19 vaccination dry run at six sites in Uttar Pradesh from 5 January

Coronavirus News Updates: In a statement, the state government said the dry run will start at 10 am in three urban and as many rural sites with a minimum of two sessions

Oxford-AstraZeneca COVID-19 vaccine will be available at cost price across world, says pharma head Olivier Nataf

Unlike the two vaccines produced by Moderna and Pfizer-BioNTech, which require ultra-cold storage, the AstraZeneca vaccine can be kept in the conventional fridge used to store vaccines around the world

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine

Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine